{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:23:58Z","timestamp":1786983838364,"version":"build-2736575974"},"reference-count":99,"publisher":"Elsevier","isbn-type":[{"value":"9780443343858","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.irn.2025.04.010","type":"book-chapter","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T16:43:27Z","timestamp":1749660207000},"page":"395-420","source":"Crossref","is-referenced-by-count":4,"title":["The protective effect of DMT against neurodegeneration"],"prefix":"10.1016","author":[{"given":"Ede","family":"Frecska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/bs.irn.2025.04.010_bib1","first-page":"L433","article-title":"Differential regulation of autophagy and mitophagy in pulmonary diseases","volume":"311","author":"Aggarwal","year":"2016","journal-title":"American Journal of Physiology: Lung Cellular and Molecular Physiology"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.010_bib2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/ana.22534","article-title":"A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis","volume":"70","author":"Al-Saif","year":"2011","journal-title":"Annals of Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.010_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends in Pharmacological Sciences"},{"issue":"7-8","key":"10.1016\/bs.irn.2025.04.010_bib4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dta.422","article-title":"A critical review of reports of endogenous psychedelic N,N-dimethyltryptamines in humans: 1955-2010","volume":"4","author":"Barker","year":"2012","journal-title":"Drug Testing and Analysis"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.010_bib5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1124\/jpet.113.208330","article-title":"Afobazole activation of sigma-1 receptors modulates neuronal responses to amyloid-beta25-35","volume":"347","author":"Behensky","year":"2013","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.010_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00441-006-0286-1","article-title":"Neuronal 5-HT metabotropic receptors: Fine-tuning of their structure, signaling, and roles in synaptic modulation","volume":"326","author":"Bockaert","year":"2006","journal-title":"Cell and Tissue Research"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.010_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2025.04.010_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fncel.2014.00213","article-title":"A molecular web: Endoplasmic reticulum stress, inflammation, and oxidative stress","volume":"8","author":"Chaudhari","year":"2014","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-024-01462-3","article-title":"N,N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer\u2019s disease by restoring neuronal sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk","volume":"16","author":"Cheng","year":"2024","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.010_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0006-2944(77)90088-6","article-title":"The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent","volume":"18","author":"Christian","year":"1977","journal-title":"Biochemical Medicine"},{"issue":"20","key":"10.1016\/bs.irn.2025.04.010_bib11","doi-asserted-by":"crossref","first-page":"11049","DOI":"10.3390\/ijms222011049","article-title":"Sigma-1 receptor Is critical for mitochondrial activity and unfolded protein response in larval zebrafish","volume":"22","author":"Crouzier","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12779-5","article-title":"Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT","volume":"7","author":"Dakic","year":"2017","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib13","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1038\/s41598-019-45812-w","article-title":"Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in mammalian brain","volume":"9","author":"Dean","year":"2019","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.010_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020705118","article-title":"Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission","volume":"118","author":"De Gregorio","year":"2021","journal-title":"Proceedings of the National Academy of Sciences, USA"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.010_bib15","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion: From mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.010_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neulet.2012.04.046","article-title":"Association between a variant of the sigma-1 receptor gene and Alzheimer\u2019s disease","volume":"517","author":"Feher","year":"2012","journal-title":"Neuroscience Letters"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.010_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000440864","article-title":"AF710B, a novel M1\/sigma1 agonist with therapeutic efficacy in animal models of Alzheimer\u2019s disease","volume":"16","author":"Fisher","year":"2016","journal-title":"Neuro-degenerative Diseases"},{"issue":"5916","key":"10.1016\/bs.irn.2025.04.010_bib18","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator","volume":"323","author":"Fontanilla","year":"2009","journal-title":"Science (New York, N. Y.)"},{"issue":"9","key":"10.1016\/bs.irn.2025.04.010_bib19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00702-013-1024-y","article-title":"A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity","volume":"120","author":"Frecska","year":"2013","journal-title":"Journal of Neural Transmission"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.010_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1254\/fpj.143.263","article-title":"Orphan receptor and chaperon functions of sigma-1 receptor","volume":"143","author":"Fukunaga","year":"2014","journal-title":"Folia pharmacologica Japonica"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jphs.2014.12.012","article-title":"The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis","volume":"127","author":"Fukunaga","year":"2015","journal-title":"Journal of Pharmacological Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1360-0443.2006.01652.x","article-title":"Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids","volume":"102","author":"Gable","year":"2007","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/bs.irn.2025.04.010_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fnins.2019.00733","article-title":"The sigma-1 receptor in cellular stress signaling","volume":"13","author":"Hayashi","year":"2019","journal-title":"Frontiers in Neuroscience"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.010_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00023210-200418050-00001","article-title":"Sigma-1 receptor ligands: Potential in the treatment of neuropsychiatric disorders","volume":"18","author":"Hayashi","year":"2004","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.010_bib25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.010_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrn3689","article-title":"Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases","volume":"15","author":"Hetz","year":"2014","journal-title":"Nature Reviews. Neuroscience"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.010_bib27","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.ajpath.2015.03.009","article-title":"Multiple mechanisms of unfolded protein response-induced cell death","volume":"185","author":"Hiramatsu","year":"2015","journal-title":"American Journal of Pathology"},{"key":"10.1016\/bs.irn.2025.04.010_bib28","series-title":"Neuroregulators and psychiatric disorders","first-page":"550","article-title":"Some general thoughts about endogenous psychotogens","author":"Hollister","year":"1977"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1681\/ASN.2015070772","article-title":"Sigma1-receptor agonism protects against renal ischemia-reperfusion injury","volume":"28","author":"Hosszu","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: Neuroplastic, immunomodulatory, and neurotransmitter mechanisms","volume":"73","author":"Inserra","year":"2021","journal-title":"Pharmacological Reviews"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.010_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11064-015-1661-7","article-title":"Chronic brain inflammation: The neurochemical basis for drugs to reduce inflammation","volume":"41","author":"Jarrott","year":"2016","journal-title":"Neurochemical Research"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.010_bib32","doi-asserted-by":"crossref","first-page":"368.e2","DOI":"10.1016\/j.cell.2013.01.004","article-title":"SnapShot: selective autophagy","volume":"152","author":"Jin","year":"2013","journal-title":"Cell"},{"key":"10.1016\/bs.irn.2025.04.010_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-12-394309-5.00006-7","article-title":"Cell biology of ischemia-reperfusion injury","volume":"298","author":"Kalogeris","year":"2012","journal-title":"International Review of Cell and Molecular Biology"},{"key":"10.1016\/bs.irn.2025.04.010_bib34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fncel.2014.00463","article-title":"Mitochondrial protection by the mixed muscarinic\/sigma1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Abeta25-35 peptide-injected mice, a nontransgenic Alzheimer\u2019s disease model","volume":"8","author":"Lahmy","year":"2015","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"9","key":"10.1016\/bs.irn.2025.04.010_bib35","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/npp.2013.70","article-title":"Blockade of Tau hyperphosphorylation and Abeta(1)(-)(4)(2) generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and sigma-1 receptor agonist, in a nontransgenic mouse model of Alzheimer\u2019s disease","volume":"38","author":"Lahmy","year":"2013","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.010_bib36","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Reports"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.010_bib37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s13311-012-0140-y","article-title":"Sigma-1R agonist improves motor function and motoneuron survival in ALS mice","volume":"9","author":"Mancuso","year":"2012","journal-title":"Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.010_bib38","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00001756-200508010-00018","article-title":"Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity","volume":"16","author":"Marrazzo","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/bs.irn.2025.04.010_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbr.2015.09.020","article-title":"Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments","volume":"296","author":"Maurice","year":"2016","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.irn.2025.04.010_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/164_2017_15","article-title":"Sigma-1 receptor in memory and neurodegenerative diseases","volume":"244","author":"Maurice","year":"2017","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.010_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-4522(97)00405-3","article-title":"Sigma-1 receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism","volume":"83","author":"Maurice","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2025.04.010_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroscience.2011.12.040","article-title":"Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N-dimethyltryptamine forming enzyme, indole-N-methyl transferase","volume":"206","author":"Mavlyutov","year":"2012","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jphs.2014.12.013","article-title":"Role of the sigma-1 receptor in amyotrophic lateral sclerosis (ALS)","volume":"127","author":"Mavlyutov","year":"2015","journal-title":"Journal of Pharmacological Sciences"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.010_bib44","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor","volume":"149","author":"Meunier","year":"2006","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.010_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12149-007-0094-z","article-title":"Low density of sigma-1 receptors in early Alzheimer\u2019s disease","volume":"22","author":"Mishina","year":"2008","journal-title":"Annals of Nuclear Medicine"},{"key":"10.1016\/bs.irn.2025.04.010_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fneur.2017.00467","article-title":"Anti-inflammatory targets for the treatment of reperfusion injury in stroke","volume":"8","author":"Mizuma","year":"2017","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0701079","article-title":"High affinity of sigma1-binding sites for sterol isomerization inhibitors: Evidence for a pharmacological relationship with the yeast sterol C8\u00b1C7 isomerase","volume":"121","author":"Moebius","year":"1997","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2025.04.010_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113245","article-title":"N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats","volume":"327","author":"Nardai","year":"2020","journal-title":"Experimental Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jphs.2014.12.005","article-title":"Role of sigma-1 receptors in neurodegenerative diseases","volume":"127","author":"Nguyen","year":"2015","journal-title":"Journal of Pharmacological Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.010_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacological Reviews"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.010_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.301","article-title":"Fluvoxamine alleviates ER stress via induction of sigma-1 receptor","volume":"5","author":"Omi","year":"2014","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.irn.2025.04.010_bib52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neulet.2013.12.005","article-title":"SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in vitro and in vivo amyotrophic lateral sclerosis models","volume":"559","author":"Ono","year":"2014","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2025.04.010_bib53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fncel.2013.00050","article-title":"The essential roles of protein-protein interaction in sigma-1 receptor functions","volume":"7","author":"Pabba","year":"2013","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"1-3","key":"10.1016\/bs.irn.2025.04.010_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2012.01.030","article-title":"The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements","volume":"682","author":"Pal","year":"2012","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib55","first-page":"97","article-title":"The role of sigma-1 receptor, an intracellular chaperone in neurodegenerative diseases","volume":"16","author":"Penke","year":"2018","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/bs.irn.2025.04.010_bib56","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nbd.2013.10.010","article-title":"Neuroprotective effects of the sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation","volume":"62","author":"Peviani","year":"2014","journal-title":"Neurobiology of Disease"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.010_bib57","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/hmg\/ddt008","article-title":"Altered localization, abnormal modification and loss of function of sigma receptor-1 in amyotrophic lateral sclerosis","volume":"22","author":"Prause","year":"2013","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.010_bib58","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s11307-015-0917-6","article-title":"Sigma-1 agonist binding in the aging rat brain: A microPET study with [(11)C]SA4503","volume":"18","author":"Ramakrishnan","year":"2016","journal-title":"Molecular Imaging and Biology: MIB: the Official Publication of the Academy of Molecular Imaging"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.010_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009019","article-title":"Psychedelics and the human receptorome","volume":"5","author":"Ray","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.irn.2025.04.010_bib60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fnmol.2017.00187","article-title":"The endoplasmic reticulum unfolded protein response in neurodegenerative disorders and its potential therapeutic significance","volume":"10","author":"Remondelli","year":"2017","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.010_bib61","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2174\/138161212799436584","article-title":"The ligand binding region of the sigma-1 receptor: Studies utilizing photoaffinity probes, sphingosine and N-alkylamines","volume":"18","author":"Ruoho","year":"2012","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jphs.2014.11.011","article-title":"The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration","volume":"127","author":"Ruscher","year":"2015","journal-title":"Journal of Pharmacological Sciences"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.010_bib63","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/npp.2008.192","article-title":"The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking","volume":"34","author":"Sabino","year":"2009","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"Pt 18","key":"10.1016\/bs.irn.2025.04.010_bib64","first-page":"4136","article-title":"The ire-1 ER stress-response pathway is required for normal secretory-protein metabolism in C. elegans","volume":"126","author":"Safra","year":"2013","journal-title":"Journal of Cell Science"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41593-022-01213-3","article-title":"Serotonin regulation of behavior via large-scale neuromodulation of serotonin receptor networks","volume":"26","author":"Salvan","year":"2023","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.irn.2025.04.010_bib66","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/bs.irn.2025.04.010_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102211","article-title":"Psychedelics for Alzheimer\u2019s disease-related dementia: Unveiling therapeutic possibilities and pathways","volume":"96","author":"Sinha","year":"2024","journal-title":"Ageing Research Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/hsz-2013-0174","article-title":"Stressed to death: Mechanisms of ER stress-induced cell death","volume":"395","author":"Sovolyova","year":"2014","journal-title":"Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.010_bib69","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archpsyc.1994.03950020009001","article-title":"Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects","volume":"51","author":"Strassman","year":"1994","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.010_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","article-title":"Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale","volume":"51","author":"Strassman","year":"1994","journal-title":"Archives of General Psychiatry"},{"issue":"12","key":"10.1016\/bs.irn.2025.04.010_bib71","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2010.08.007","article-title":"The sigma-1 receptor chaperone as an inter-organelle signaling modulator","volume":"31","author":"Su","year":"2010","journal-title":"Trends in Pharmacological Sciences"},{"issue":"61","key":"10.1016\/bs.irn.2025.04.010_bib72","doi-asserted-by":"crossref","first-page":"pe12","DOI":"10.1126\/scisignal.261pe12","article-title":"When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor","volume":"2","author":"Su","year":"2009","journal-title":"Science Signaling"},{"issue":"4849","key":"10.1016\/bs.irn.2025.04.010_bib73","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1126\/science.2832949","article-title":"Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems","volume":"240","author":"Su","year":"1988","journal-title":"Science (New York, N. Y.)"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.010_bib74","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","article-title":"The sigma-1 receptor as a pluripotent modulator in living systems","volume":"37","author":"Su","year":"2016","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/tnsci-2016-0007","article-title":"The serotonergic system and cognitive function","volume":"7","author":"Svob Strac","year":"2016","journal-title":"Translational Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.010_bib76","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4103\/1673-5374.179041","article-title":"Dimethyltryptamine (DMT): A biochemical Swiss Army knife in neuroinflammation and neuroprotection?","volume":"11","author":"Szabo","year":"2016","journal-title":"Neural regeneration research"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.010_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106533","article-title":"Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells","volume":"9","author":"Szabo","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.irn.2025.04.010_bib78","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fnins.2016.00423","article-title":"The endogenous hallucinogen and trace amine N,N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells","volume":"10","author":"Szabo","year":"2016","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.irn.2025.04.010_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108612","article-title":"N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain","volume":"192","author":"Szabo","year":"2021","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.010_bib80","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.bbagen.2012.12.029","article-title":"Stimulationof sigma1-receptor restores abnormal mitochondrial Ca(2)(+) mobilization and ATP production following cardiac hypertrophy","volume":"1830","author":"Tagashira","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.010_bib81","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jnr.10441","article-title":"Neuroplasticity in Alzheimer\u2019s disease","volume":"70","author":"Teter","year":"2002","journal-title":"Journal of Neuroscience Research"},{"issue":"47","key":"10.1016\/bs.irn.2025.04.010_bib82","doi-asserted-by":"crossref","first-page":"E6562","DOI":"10.1073\/pnas.1518894112","article-title":"Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope","volume":"112","author":"Tsai","year":"2015","journal-title":"Proceedings of the National Academy of Sciences, USA"},{"issue":"12","key":"10.1016\/bs.irn.2025.04.010_bib83","first-page":"1461","article-title":"Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders","volume":"18","author":"Tsai","year":"2014","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.010_bib84","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","article-title":"5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex","volume":"17","author":"Vaidya","year":"1997","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2025.04.010_bib85","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnsyn.2020.00034","article-title":"Psychedelics as a treatment for Alzheimer\u2019s disease dementia","volume":"12","author":"Vann Jones","year":"2020","journal-title":"Frontiers in Synaptic Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.010_bib86","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/npp.2008.212","article-title":"Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-induced toxicity in mice","volume":"34","author":"Villard","year":"2009","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.010_bib87","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2174\/1567205012666150710095035","article-title":"Dysfunction of endoplasmic reticulum (ER) and mitochondria (MT) in Alzheimer\u2019s disease: The role of the ER-MT cross-talk","volume":"12","author":"Volgyi","year":"2015","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/bs.irn.2025.04.010_bib88","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2015.04.009","article-title":"Sigma-1 receptor regulates the oxidative stress response in primary retinal Muller glial cells via NRF2 signaling and system xc(-), the Na(+)-independent glutamate-cystine exchanger","volume":"86","author":"Wang","year":"2015","journal-title":"Free Radical Biology & Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib89","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12974-016-0660-1","article-title":"Class I PI3K inhibitor ZSTK474 mediates a shift in microglial\/macrophage phenotype and inhibits inflammatory response in mice with cerebral ischemia\/reperfusion injury","volume":"13","author":"Wang","year":"2016","journal-title":"Journal of Neuroinflammation"},{"issue":"12","key":"10.1016\/bs.irn.2025.04.010_bib90","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.15252\/emmm.201606403","article-title":"Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS","volume":"8","author":"Watanabe","year":"2016","journal-title":"EMBO Molecular Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib91","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12929-017-0380-6","article-title":"Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases","volume":"24","author":"Weng","year":"2017","journal-title":"Journal of Biomedical Science"},{"key":"10.1016\/bs.irn.2025.04.010_bib92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euroneuro.2023.07.003","article-title":"The potential of psychedelics for the treatment of Alzheimer\u2019s disease and related dementias","volume":"76","author":"Winkelman","year":"2023","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib93","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0269881113513852","article-title":"Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample","volume":"28","author":"Winstock","year":"2014","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2025.04.010_bib94","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainres.2015.05.006","article-title":"Dehydroepiandrosterone administration improves memory deficits following transient brain ischemia through sigma-1 receptor stimulation","volume":"1622","author":"Yabuki","year":"2015","journal-title":"Brain Research"},{"key":"10.1016\/bs.irn.2025.04.010_bib95","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fphar.2015.00225","article-title":"The role of serotonin 5-HT2A receptors in memory and cognition","volume":"6","author":"Zhang","year":"2015","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.010_bib96","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","article-title":"Ischemia-reperfusion injury: Molecular mechanisms and therapeutic targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.010_bib97","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1021\/acschemneuro.1c00032","article-title":"The protective effects of dexmedetomidine against hypoxia\/reoxygenation-induced inflammatory injury and permeability in brain endothelial cells mediated by sigma-1 receptor","volume":"12","author":"Zhao","year":"2021","journal-title":"ACS Chemical Neuroscience"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.010_bib98","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10495-018-1495-2","article-title":"Sigma-1 receptor protects against endoplasmic reticulum stress-mediated apoptosis in mice with cerebral ischemia\/reperfusion injury","volume":"24","author":"Zhao","year":"2019","journal-title":"Apoptosis: an International Journal on Programmed Cell Death"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.010_bib99","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00000441-199404000-00009","article-title":"Mechanisms of reperfusion injury","volume":"307","author":"Zimmerman","year":"1994","journal-title":"American Journal of the Medical Sciences"}],"container-title":["International Review of Neurobiology","Psychedelics in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477422500025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477422500025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T18:53:08Z","timestamp":1750272788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S007477422500025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443343858"],"references-count":99,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2025.04.010","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}